<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Katanga J</submitter><funding>Danish International Development Agency</funding><pagination>e0218559</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6583973</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(6)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To examine the test performance of careHPV, Hybrid Capture2 (HC2) and visual inspection with acetic acid (VIA) for detection of cytologically diagnosed high-grade cervical lesions or cancer (HSIL+).&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Ocean Road Cancer Institute (ORCI) and Kilimanjaro Christian Medical Center (KCMC), Tanzania.&lt;h4>Population&lt;/h4>Women attending routine cervical cancer screening.&lt;h4>Method&lt;/h4>We enrolled 4080 women (25-60 years) in the study. The women were interviewed on lifestyle habits, and tested for HIV. A cervical specimen for careHPV testing (performed at ORCI and KCMC), and a liquid-based cytology sample for HPV DNA detection using HC2 (performed at Tuebingen University Hospital, Germany) and for cytology assessment (performed at Ve</pubmed_abstract><journal>PloS one</journal><pubmed_title>Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.</pubmed_title><pmcid>PMC6583973</pmcid><funding_grant_id>14-TAN-P02</funding_grant_id><pubmed_authors>Manongi R</pubmed_authors><pubmed_authors>Waldstrom M</pubmed_authors><pubmed_authors>Pembe AB</pubmed_authors><pubmed_authors>Mwaiselage J</pubmed_authors><pubmed_authors>Rasch V</pubmed_authors><pubmed_authors>Iftner T</pubmed_authors><pubmed_authors>Katanga J</pubmed_authors><pubmed_authors>Wu CS</pubmed_authors><pubmed_authors>Kjaer SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.</name><description>&lt;h4>Objective&lt;/h4>To examine the test performance of careHPV, Hybrid Capture2 (HC2) and visual inspection with acetic acid (VIA) for detection of cytologically diagnosed high-grade cervical lesions or cancer (HSIL+).&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Ocean Road Cancer Institute (ORCI) and Kilimanjaro Christian Medical Center (KCMC), Tanzania.&lt;h4>Population&lt;/h4>Women attending routine cervical cancer screening.&lt;h4>Method&lt;/h4>We enrolled 4080 women (25-60 years) in the study. The women were interviewed on lifestyle habits, and tested for HIV. A cervical specimen for careHPV testing (performed at ORCI and KCMC), and a liquid-based cytology sample for HPV DNA detection using HC2 (performed at Tuebingen University Hospital, Germany) and for cytology assessment (performed at Ve</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-05-29T21:05:11.616Z</modification><creation>2025-05-29T21:05:11.616Z</creation></dates><accession>S-EPMC6583973</accession><cross_references><pubmed>31216333</pubmed><doi>10.1371/journal.pone.0218559</doi></cross_references></HashMap>